MARLBOROUGH, Mass., Boston Scientific Corporation has received Food and Drug Administration (FDA) approval for the Innova™ Vascular Self-Expanding Stent System, an advanced treatment option for ...
NATICK, Mass., Boston Scientific Corporation has completed enrollment in the SuperNOVA trial – a global, single arm, prospective, multicenter trial evaluating the long-term (12 month) safety and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback